Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in Texas
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Carr, Christopher MD | $117.75 | 91 |
| Smith, Wade M.D. | $96.47 | 82 |
| Speck, Fred M.D. | $111.03 | 42 |
| Currimbhoy, Sharif M.D. | $116.81 | 41 |
| Franks, Hayden M.D. | $107.32 | 36 |
| Young, Jeffrey M.D. | $120.18 | 36 |
| Rowley, Matthew MD | $100.72 | 36 |
| Gilmore, William MD | $106.63 | 34 |
| Chappell, Lauren PA-C | $93.72 | 31 |
| Ramolia, Paras M.D. | $117.62 | 31 |
Texas Pricing in Context
In Texas, CPT code 17271 (Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm) carries an average Medicare payment of $105.62 — 5% above the national benchmark of $100.30. 515 providers across the state submitted claims for this procedure in 2023, performing 2.4K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $333.61, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Texas lands near $319.89, with self-pay cash prices typically around $196.06. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cost in Texas?
The average Medicare payment for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in Texas is $105.62, which is 5% above the national average of $100.30. Providers in TX typically bill $333.61 for this procedure.
What does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cost with insurance in Texas?
With commercial insurance in Texas, Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm costs an estimated $319.89. Without insurance, the estimated cash price is $196.06. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in Texas?
515 providers in Texas billed Medicare for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in 2023, performing 2.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cheaper in Texas than the national average?
No — Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm costs 5% above the national average in Texas. The state average Medicare payment is $105.62 compared to $100.30 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.